SLC31A1 and neoplasm: Second, in gliomas, elevated SLC31A1 expression is associated with M2 macrophage enrichment and poor prognosis but inversely links to anti-tumor immune cells (plasmacytoid dendritic cells (DCs), CD56bright NK cells, CD8+ T cells) 23, 33.